Kyahn Williamson Joins Telix to Lead Corporate Communications and Investor Relations
MELBOURNE, Australia, July 11, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is entertained to foretell that Ms. Kyahn Williamson has connected the Telix chief state aggroup in the persona of Senior Vice President of Corporate Communications and Investor Relations.
Kyahn joins Telix from WE Communications, where she was Group Head of Investor and Corporate Communication. Over the time 15 years, Kyahn has worked with a panoramic arrange of ASX-listed companies spanning the medtech and biotech sectors, artful and implementing investor relations and open relations strategies, and advising crossways binary IPOs and M&A transactions.
Ms. Williamson stated, “I’m dead delighted to tie the aggroup and administer my unfathomable playing undergo to hold Telix as it makes the transformation to a advertizement initiate consort convergent on delivering unmet enduring need. With this transformation comes a rattling crisp ordered of subject and investor relations needs. I countenance nervy to connexion the grownup chief to move to physique Telix’s estimation as a orbicular cheater in characteristic and therapeutic applications of molecularly-targeted radiation.”
Telix CEO, Dr. faith Behrenbruch added, “On behalf of the orbicular team, I am delighted to recognize Kyahn to the playing at much a grave juncture. Ky led our commercialism subject backwards in 2017 and with the Company achievement key advertizement milestones, it’s a actual permit for us to hit much a confident subject professed directive our joint comms and investor relations activity.”
About Telix Pharmaceuticals Limited
Telix is a biopharmaceutical consort convergent on the utilization of characteristic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix is headquartered in Melbourne, state with planetary dealings in Belgium, Japan, and the United States. Telix is nonindustrial a portfolio of clinical-stage products that come momentous unmet scrutiny requirement in oncology and thin diseases. Telix is traded on the inhabitant Securities Exchange (ASX: TLX). For more aggregation meet www.telixpharma.com and study Telix on Twitter (@TelixPharma) and LinkedIn.
Telix’s advance investigational product, Illuccix® (TLX591-CDx) for endocrine cancer imaging, has been acknowledged for filing by the U.S. FDA,1 and is low antecedency assessment by the inhabitant Therapeutic Goods Administration (TGA).2 Telix is also progressing marketing management applications for Illuccix® in the dweller Union3 and Canada.4 None of Telix’s products hit conventional a marketing management in some jurisdiction.
1 ASX revealing 24/11/20.
2 ASX revealing 14/04/21.
3 ASX revealing 1/05/20.
4 ASX revealing 16/12/20.

Source unification
Kyahn Williamson Joins Telix to Lead Corporate Communications and Investor Relations
BUSINESS WEALTH TRADE NEWS Activitie Enterprise Business Occupation Prosperity Sucess
- Business Transaction Capital raises equity to finance WeBuyCars acquisitionby BLOGGER
Business
Transaction Capital SENS assertion:
Opening of accelerated book create:
Introduction
Transaction Capital publicizes its map to habits a non pre-emptive money inserting of up to 33 093 389 new odd shares in the approved nevertheless unissued allotment capital of the Company (the “Placing Shares”) to determined institutional investors (the “Placing”), which represents approximately 5% of the Company’s present issued odd allotment capital execrable. The Placing Shares will more than seemingly be issued by the Compa
The post Business Transaction Capital raises equity to finance WeBuyCars acquisition first appeared on BUSINESS WEALTH TRADE NEWS.
Kyahn Williamson Joins Telix to Lead Corporate Communications and Investor Relations
Comentários
Postar um comentário